D J Chaplin - Concepedia

Author

D J Chaplin

Mount Vernon Hospital

Also Known As

D J Chaplin, D. Chaplin, D. J. Chaplin, D.J. CHAPLIN, D.J. Chaplin, DJ Chaplin, Dai Chaplin, Dai J. Chaplin

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Mount Vernon Hospital Hammersmith Hospital Danish Cancer Society University College London Cancer Research UK

About

D J Chaplin is an author at Mount Vernon Hospital specializing in medicine, tumor biology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	3.2K
2	Health Sciences	5	5	1.6K
3	Engineering	2	2	151
4	Biochemistry	2	2	63
5	Natural Sciences	1	1	53

D J Chaplin

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the welfare and use of animals in cancer research Paul Workman, Eric O. Aboagye, Frances R. Balkwill, British Journal of Cancer Cancer ManagementAnimal WelfarePathologyTumor BiologyLaboratory Animal Study	2010	1.4K
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. G. Dark, S A Hill, Vivien E. Prise, PubMed Vascular ShutdownTumor BiologyOncologyCancer Cell BiologySelective Toxicity	1997	624
Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts Moritz A. Konerding, W Malkusch, B Klapthor, British Journal of Cancer	1999	216
Effect of Nicotinamide on the Microregional Heterogeneity of Oxygen Delivery Within a Murine Tumor D J Chaplin, Michael R. Horsman, Martin J. Trotter JNCI Journal of the National Cancer Institute Microregional HeterogeneityBiomedical EngineeringTumor BiologyMurine TumorNanomedicine	1990	142
Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours Peggy L. Olive, D J Chaplin, R E Durand British Journal of Cancer Steroid MetabolismMedicineMurine TumoursPathologyHoechst 33342	1985	139
Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents. D J Chaplin, George R. Pettit, C.S. Parkins, PubMed Antivascular ApproachesBlood Flow ReductionDrug TargetingOncologyMedicine	1996	118
Cell selection from a murine tumour using the fluorescent probe Hoechst 33342 D J Chaplin, R E Durand, Peggy L. Olive British Journal of Cancer Tumor BiologyEndocrine OncologyCell SelectionTumoral PathologyOncologic Imaging	1985	117
Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate. RB Pedley, Sally A. Hill, G Boxer, PubMed Colorectal XenograftsImmunologyPathologyMetronomic ChemotherapyImmunotherapy	2001	109
Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours D J Chaplin, SA Hill British Journal of Cancer Temporal HeterogeneityHistopathologyBiological MicroenvironmentsBlood CellCell Migration	1995	108
Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. Gillian M. Tozer, Vivien E. Prise, D J Chaplin PubMed HypertensionCardiovascular PharmacologyPharmacotherapyCardiovascular ToxicityTumor Biology	1997	99

Page 1